Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
Head & Neck · 2025
DOI: 10.1002/hed.28121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Chao Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 32 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To investigate the efficacy and safety of local intra‐arterial chemotherapy combined with immune checkpoint inhibitors in the treatment of unresectable head and neck squamous cell carcinoma (HNSCC).
Methods
A retrospective analysis was conducted on the clinical data of eight patients diagnosed with unresectable HNSCC at our hospital from January to December 2023. All patients were diagnosed by pathological diagnosis and treated with intra‐arterial chemotherapy combined with immune checkpoint inhibitors. The overall response rate (ORR), progression‐free survival (PFS), overall survival (OS), and adverse reactions were observed.
Results
The study cohort consisted of seven men and one woman, with a median age of 58.4 ± 13.1 years. Five patients were at stage IVA, one at stage IVB, and two at stage IVC. One patient was lost to follow‐up, and among the 7 patients with complete data, the ORR was 85.7%. The median PFS and OS in the overall population were not achieved, and the patient tolerated the treatment well with no significant adverse effects.
Conclusion
Local intra‐arterial chemotherapy combined with immune checkpoint inhibitors is an important future exploration direction for the treatment of unresectable HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Chao Yang
Zitieren
APA
Yang, C., Zhang, J. L., Li, Z., Liang, X. H., & Zhao, H. W. (2025). Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. https://doi.org/10.1002/hed.28121
Vancouver
Yang C, Zhang JL, Li Z, Liang XH, Zhao HW. Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma. Head & Neck. 2025. doi:10.1002/hed.28121
BibTeX
@article{Yang2025,
author = {Yang, Chao and Zhang, Jin-Long and Li, Zheng and Liang, Xi-Hong and Zhao, Hong-Wei},
title = {Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28121}
}
EUVIMED